$71.760
-0.158 (-0.22%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
TARS Prediction & Forecast by Similar Chart Analysis
Alphio's TARS stock price prediction model matches the current Tarsus Pharmaceuticals Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $73.94 (+3.04%). The 1-week path is $79.82 (+11.23%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Tarsus Pharmaceuticals Inc Stock?
Tarsus Pharmaceuticals Inc is a good buy right now due to its strong financial performance, including a gross margin of 93% and a projected revenue increase with Q2 sales reaching $173.9 million. The stock is currently priced at $71.76, with analysts setting a price target of $100, indicating a potential upside of 39%. The main risk is the negative net income of $18.55 million reported in Q2 2026, which investors should monitor closely.
TARS stock price ended at $71.76 on Friday, after losing -0.22%
Tarsus Pharmaceuticals Inc (TARS) last closed at $71.76, losing -0.22%. These facts feed the 1-day and 1-week TARS price prediction above.
Forecast Drivers
Tarsus Pharmaceuticals Inc (TARS) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bearish
Seasonality
Bearish
SMA 20
Bullish
SMA 200
Bullish
Similar Chart Patterns
Stocks whose recent price path most closely matches TARS, ranked by similarity.
Seasonality analysis for TARS
Historically the probability of a positive August return for TARS is 47.62%. October offers the highest probability of a positive month at 100.00%, while June is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for TARS
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Aug 2026 | $59.59 | $105.90 | $115.37 | +47.58% |
| Sep 2026 | $49.74 | $79.56 | $103.20 | +10.87% |
| Oct 2026 | $104.14 | $127.89 | $153.02 | +78.22% |
| Nov 2026 | $70.73 | $114.56 | $154.39 | +59.64% |
| Dec 2026 | $99.13 | $101.61 | $147.86 | +41.60% |
In 2026, Tarsus Pharmaceuticals Inc (TARS) is projected to range from $49.74 to $154.39.
Tarsus Pharmaceuticals Inc 2026 monthly forecast
In Aug 2026, Tarsus Pharmaceuticals Inc is projected to average $105.90, with a low of $59.59 and high of $115.37.
In Sep 2026, Tarsus Pharmaceuticals Inc is projected to average $79.56, with a low of $49.74 and high of $103.20.
In Oct 2026, Tarsus Pharmaceuticals Inc is projected to average $127.89, with a low of $104.14 and high of $153.02.
In Nov 2026, Tarsus Pharmaceuticals Inc is projected to average $114.56, with a low of $70.73 and high of $154.39.
In Dec 2026, Tarsus Pharmaceuticals Inc is projected to average $101.61, with a low of $99.13 and high of $147.86.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.